Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia

被引:52
|
作者
Hefazi, Mehrdad [1 ]
Litzow, Mark R. [1 ]
机构
[1] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
关键词
T cell acute lymphoblastic leukemia; Early Tcell precursor acute lymphoblastic leukemia; Minimal residual disease; Nelarabine; Targeted therapies; MINIMAL RESIDUAL DISEASE; HIGH-DOSE METHOTREXATE; ADULT PATIENTS; HYPER-CVAD; PEGYLATED-ASPARAGINASE; CLINICAL-SIGNIFICANCE; MUTATIONS PREDICT; FBXW7; MUTATIONS; RELAPSE RISK; FOLLOW-UP;
D O I
10.1007/s11899-018-0455-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article provides an overview of the current knowledge regarding the biology and treatment of T cell acute lymphoblastic leukemia (T-ALL) and highlights the most recent findings in this field over the past 5 years. Remarkable progress has been made in the genomic landscape of T-ALL over the past few years. The discovery of activating mutations of NOTCH1 and FBXW7 in a majority of patients has been a seminal observation, with several early phase clinical trials currently exploring these as potential therapeutic targets. Characterization of early T cell precursor ALL, incorporation of minimal residual disease assessment into therapeutic protocols, and use of pediatric-intensive regimens along with judicious use of allogeneic HCT have significantly improved risk stratification and treatment outcomes. Improved risk stratification and the use of novel targeted therapies based on recent genomic discoveries are expected to change the therapeutic landscape of T-ALL and hopefully improve the outcomes of this historically poor prognosis disease.
引用
收藏
页码:265 / 274
页数:10
相关论文
共 50 条
  • [1] Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia
    Mehrdad Hefazi
    Mark R. Litzow
    Current Hematologic Malignancy Reports, 2018, 13 : 265 - 274
  • [2] Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia
    Hefazi, Mehrdad
    Litzow, Mark R.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2018, 8 : 47 - 61
  • [3] RECENT ADVANCES IN THE BIOLOGY AND TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    JACOBS, AD
    GALE, RP
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (19): : 1219 - 1231
  • [4] Recent advances in the treatment of acute lymphoblastic leukemia
    Rafei, Hind
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    LEUKEMIA & LYMPHOMA, 2019, 60 (11) : 2606 - 2621
  • [5] ACUTE LYMPHOBLASTIC-LEUKEMIA - RECENT ADVANCES IN BIOLOGY AND THERAPY
    CHAMPLIN, R
    GALE, RP
    BLOOD, 1989, 73 (08) : 2051 - 2066
  • [6] Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
    Malczewska, Marta
    Kosmider, Kamil
    Bednarz, Kinga
    Ostapinska, Katarzyna
    Lejman, Monika
    Zawitkowska, Joanna
    CANCERS, 2022, 14 (08)
  • [7] Recent advances in acute myeloid leukemia stem cell biology
    Horton, Sarah J.
    Huntly, Brian J. P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (07): : 966 - 974
  • [8] Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults
    Anand A. Patel
    Joseph Thomas
    Alexandra E. Rojek
    Wendy Stock
    Current Treatment Options in Oncology, 2020, 21
  • [9] Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress
    Goto, Hiroaki
    PEDIATRICS INTERNATIONAL, 2015, 57 (06) : 1059 - 1066
  • [10] Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults
    Patel, Anand A.
    Thomas, Joseph
    Rojek, Alexandra E.
    Stock, Wendy
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (07)